Provided by Tiger Trade Technology Pte. Ltd.

Insulet

227.10
-1.5300-0.67%
Post-market: 227.230.1300+0.06%17:56 EDT
Volume:1.06M
Turnover:241.43M
Market Cap:15.98B
PE:65.28
High:230.25
Open:227.68
Low:224.32
Close:228.63
52wk High:354.88
52wk Low:216.49
Shares:70.35M
Float Shares:70.08M
Volume Ratio:0.92
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.48
EPS(LYR):3.48
ROE:18.12%
ROA:9.43%
PB:10.54
PE(LYR):65.28

Loading ...

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 07, 2025

Insulet Is Maintained at Buy by Jefferies

Dow Jones
·
Nov 07, 2025

Insulet’s Strong Sales and Strategic Growth Drive Buy Rating

TIPRANKS
·
Nov 07, 2025

Insulet price target raised to $400 from $375 at Jefferies

TIPRANKS
·
Nov 07, 2025

Insulet’s Strong Financial Performance and Growth Prospects Earn Buy Rating from Analyst

TIPRANKS
·
Nov 07, 2025

Stock Track | Insulet Plummets 5.11% Despite Strong Q3 Results and Raised Guidance

Stock Track
·
Nov 07, 2025

Stock Track | Insulet Plummets 5.11% Despite Q3 Earnings Beat and Raised Guidance

Stock Track
·
Nov 07, 2025

Stock Track | Insulet Soars 5.25% Pre-Market on Strong Q3 Results and Raised Guidance

Stock Track
·
Nov 06, 2025

Sector Update: Health Care Stocks Mixed Premarket Thursday

MT Newswires Live
·
Nov 06, 2025

BUZZ-Insulet rises after beating quarterly estimates

Reuters
·
Nov 06, 2025

Insulet tops quarterly estimates on demand for wearable insulin pumps

Reuters
·
Nov 06, 2025

BUZZ-Moderna climbs on smaller-than-expected Q3 loss

Reuters
·
Nov 06, 2025

Insulet Corporation Highlights Omnipod 5 Expansion and Innovation in Diabetes Technology in Investor Presentation

Reuters
·
Nov 06, 2025

MORNING BID AMERICAS-Selloff abates as economy hums, layoffs rise

Reuters
·
Nov 06, 2025

Insulet Q3 revenue, profit beat expectations on Omnipod demand

Reuters
·
Nov 06, 2025

BRIEF-Insulet Q3 Revenue USD 706.3 Million Vs. IBES Estimate USD 677 Million

Reuters
·
Nov 06, 2025

Insulet Outlook FY Revenue Growth 28-29%

THOMSON REUTERS
·
Nov 06, 2025

Insulet Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Nov 06, 2025

Insulet, Uber And A Financial Stock On CNBC's 'Final Trades'

Benzinga
·
Nov 05, 2025

Barclays Adjusts Price Target on Insulet to $301 From $300, Maintains Equalweight Rating

MT Newswires Live
·
Nov 05, 2025